Product Information
AMLODIPINE-OLMESARTAN 5-20 MG is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.2257 per EA under NDC 33342019010. Its NADAC has been published 501 times since Jan 18, 2017.
FDA first approved this application on Oct 26, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5; 20 mg/1; mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342019010
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA206884FDA Approved
10/26/2016
TE Code
AB
On Market Since
10/27/2016
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-OLMESARTAN 5-20 MG has been published 501 times since Jan 18, 2017, and over the history we have for it it has declined 75.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2257 per EA |
|---|---|
| All-time high | $1.0059 (Apr 12, 2017) |
| All-time low | $0.2257 (Aug 19, 2026) |
| 52-week high | $0.2866 |
| 52-week low | $0.2257 |
| Median price | $0.4149 |
| Average price | $0.4760 |
| Largest weekly change | +64.3% (Jul 21, 2021) |
| Weeks tracked | 501 |
| Tracking since | Jan 18, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMLODIPINE-OLMESARTAN 5-20 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-OLMESARTAN 5-20 MG, manufactured by Macleods Pharmaceuticals Limited, is $0.2257 per EA (NDC 33342019010), effective Aug 19, 2026.
How has the price of AMLODIPINE-OLMESARTAN 5-20 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-OLMESARTAN 5-20 MG has declined 75.6%. It has been tracked across 501 weekly CMS publications since Jan 18, 2017.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-OLMESARTAN 5-20 MG?
Since Jan 18, 2017, the NADAC for AMLODIPINE-OLMESARTAN 5-20 MG has ranged from a low of $0.2257 (Aug 19, 2026) to a high of $1.0059 (Apr 12, 2017), with a median of $0.4149 per EA.
Are there cheaper alternatives to AMLODIPINE-OLMESARTAN 5-20 MG?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-OLMESARTAN 5-20 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures AMLODIPINE-OLMESARTAN 5-20 MG?
AMLODIPINE-OLMESARTAN 5-20 MG (NDC 33342019010) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.